Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Wegovy is specifically approved for weight management in non-diabetic people with obesity or overweight plus health complications
According to a meta-analysis evaluating 453 trials and 21 antidiabetic treatments, oral semaglutide reduces all-cause mortality and cardiovascular death, with the lowest odds ratios (ORs) among the treatments evaluated (empagliflozin, liraglutide, extended-release exenatide, dapagliflozin, dulaglutide, lixisenatide, canagliflozin, pioglitazone, DPP-4 inhibitors, subcutaneous semaglutide, sulphonylureas) [56]
However, not all trials have been successful
Moreover, taking into account numerous clinical studies and experimental data showing that the pathogenesis of depression is not limited to the brain, but may also result from an impaired cross-talk between the central nervous system and other systems in the body, particularly the immune, endocrine and digestive systems, therapeutic GLP-1 analogs such as exendin-4 or liraglutide can also normalize their functioning in many cases, thus preventing the occurrence of maladaptive brain changes associated with depressive symptoms
US$ 23.48
US$ 20.52
US$ 21.36
US$ 29.75
US$ 26.46
US$ 26.43
